Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for BioLineRx Ltd. (BLRX)

« Back to company index

BLRX Chatter Timeline

Stock Ticker for BLRX

Most Active Tweeters for BLRX

UserTweets
@Tickeron 13
@coreinv1 10
@TheFortuneTell5 7
@mediasentiment 7
@PennySearch 6

Recent Tweets for BLRX

Tickeron @Tickeron
$BLRX in -3.7% Downtrend, sliding for three consecutive days on January 24, 2022. View odds for this and other indi… https://t.co/96nuhe1swC
January 25th 2022, 6:01am
ChartMill @ChartMill
$BLRX shows a strong growth in EPS: 49.25%. https://t.co/jOtbxZNaEz https://t.co/1bp8p2HkBh
January 24th 2022, 9:01pm
StckPro @StckPro
$BLRX NEW ARTICLE : BioLineRx completes enrollment in phase 1/2a trial of cancer vaccine AGI-134… https://t.co/0d2EXrQvrc
January 24th 2022, 2:01pm
MarketCurrents @MarketCurrents
$BLRX - BioLineRx completes enrollment in phase 1/2a trial of cancer vaccine AGI-134 https://t.co/WEgFjie2Gq
January 24th 2022, 2:01pm
GeorgeB14941177 @GeorgeB14941177
$BLRX BioLineRx Announces Completion of Enrollment of Phase 1/2a Study of Innovative Intratumoral Cancer Vaccine, A… https://t.co/y33VmUALWZ
January 24th 2022, 12:01pm
investor_feed @investor_feed
$BLRX 6-K Bioline Rx (24 Jan, 7:11am) ? BioLineRx Announces Completion of Enrollment of Phase 1/2a… https://t.co/XMTMQuwLz0
January 24th 2022, 12:01pm
newsinthemarket @newsinthemarket
BioLineRx completes enrollment in Phase Phase 1/2a study of AGI-134 $BLRX
January 24th 2022, 12:01pm
TeamofStockTra @TeamofStockTra
$BLRX - BioLineRx Announces Completion of Enrollment of Phase 1/2a Study of Innovative Intratumoral Cancer Vaccine,… https://t.co/mLNDCFMV0S
January 24th 2022, 12:01pm
AkramMSiddique @AkramMSiddique
$BLRX - BioLineRx Announces Completion of Enrollment of Phase 1/2a Study of Innovative Intratumoral Cancer Vaccine,… https://t.co/jb5zlGO49y
January 24th 2022, 12:01pm
FlashAlert_me @FlashAlert_me
$BLRX [15s. delayed]: Issued Press Release on January 24, 07:00:00: BioLineRx Announces Completion of Enrollment of… https://t.co/mRarE1B2k2
January 24th 2022, 12:01pm
PennyStockNews5 @PennyStockNews5
$BLRX ? Sentiments: title -0.2263 | summary 0.743 Pre-Price: 1.82 | Bid: 0 | Ask: 0 Volume: 429,532 https://t.co/l0ETp9e9Sn
January 24th 2022, 12:01pm
James__BondOO7 @James__BondOO7
RT @stock_titan: $BLRX BioLineRx Announces Completion of Enrollment of Phase 1/2a Study of Innovative Intratumoral Cancer Vaccine, AGI-134,…
January 24th 2022, 12:01pm
StockNewsBot2 @StockNewsBot2
$BLRX BioLineRx Announces Completion of Enrollment of Phase 1/2a Study of Innovative Intratumoral Cancer Vaccine, A… https://t.co/vuT3EIQtqS
January 24th 2022, 12:01pm
stock_titan @stock_titan
$BLRX BioLineRx Announces Completion of Enrollment of Phase 1/2a Study of Innovative Intratumoral Cancer Vaccine, A… https://t.co/2ESrOmRvmC
January 24th 2022, 12:01pm
Tickeron @Tickeron
$BLRX in -8.96% Downtrend, sliding for three consecutive days on January 21, 2022. View odds for this and other ind… https://t.co/8bxds5aCWR
January 24th 2022, 4:01am
TheFortuneTell5 @TheFortuneTell5
Commented on $BLRX - BioLineRx: A Top Candidate For A Takeover Before 2022 Ends. https://t.co/5OYGITulKI
January 23rd 2022, 7:01pm
TheFortuneTell5 @TheFortuneTell5
Commented on $BLRX - BioLineRx: A Top Candidate For A Takeover Before 2022 Ends. https://t.co/us5r3VAlAs
January 23rd 2022, 10:01am
PennySearch @PennySearch
$BLRX HC Wainwright & Co. gave BLRX a Buy stock rating on 2021-02-23. Find top penny stocks with PennySearch bef… https://t.co/LYnZrfB0Mr
January 22nd 2022, 1:01pm
coreinv1 @coreinv1
$BLRX do not cover patent protection nor management in corporate presentation, that's not great. Nor safety as ment… https://t.co/NG83rbanBd
January 22nd 2022, 12:01pm
Gambiste1 @Gambiste1
RT @coreinv1: $BLRX in pancreatic cancer I don't (for now) proscribe much value due to lack of durability and differentiation. Lack of deta…
January 22nd 2022, 11:01am
coreinv1 @coreinv1
$BLRX biggest issue here is only few catalysts. Pre-NDA went well. NDA submission is a bit of non-event. Only FDA r… https://t.co/9d8Xkcv33B
January 22nd 2022, 11:01am
coreinv1 @coreinv1
$BLRX also have a second drug AGI-134 that coats tumor cells with alpha-gal to make them look like foreign tissue.… https://t.co/QTkUeSua1z
January 22nd 2022, 11:01am
coreinv1 @coreinv1
$BLRX in pancreatic cancer I don't (for now) proscribe much value due to lack of durability and differentiation. La… https://t.co/1f4xixmLxx
January 22nd 2022, 11:01am
coreinv1 @coreinv1
$BLRX Motixafortide is a best-in-class CXCR4 antagonist for multiple indications. https://t.co/sS3nqNL7uX.
January 22nd 2022, 11:01am
rami__aleme @rami__aleme
RT @leandrosalama: Took 2 small losses with $CCCL and then nailed the drop from 1.4 to 1.06. Chased $BLRX a bid because the fundamentals be…
January 22nd 2022, 2:01am
Andreacocco87 @Andreacocco87
$BLRX BioLineRx Announces Successful Completion of Pre-NDA Meeting with FDA for Motixafortide for Stem Cell Mobiliz… https://t.co/kxWzm8ctJh
January 21st 2022, 4:01pm
Tickeron @Tickeron
$BLRX in -13.3% Downtrend, declining for three consecutive days on January 20, 2022. View odds for this and other i… https://t.co/u3J5rvz6KJ
January 21st 2022, 9:01am
Tickeron @Tickeron
How does this affect your portfolio? $BLRX price may climb as it broke lower Bollinger Band. #BioLineRx… https://t.co/lYamEcKLwK
January 21st 2022, 9:01am
PennySearch @PennySearch
$BLRX HC Wainwright & Co. gave BLRX a Buy stock rating on 2021-02-23. Find top penny stocks with PennySearch bef… https://t.co/zndJ8MgqZJ
January 21st 2022, 9:01am
TheFortuneTell5 @TheFortuneTell5
Commented on $BLRX - BioLineRx: A Top Candidate For A Takeover Before 2022 Ends. https://t.co/C4CwvloM6y
January 20th 2022, 11:01pm
TradeWithAlerts @TradeWithAlerts
Nice print for $BLRX Size: 260473 Price: 1.89 Amount: $492,293.97 Time: 1600 See more: https://t.co/DC99ZKy7SX Join… https://t.co/CeFC6ThoeW
January 20th 2022, 9:01pm
A1Syad @A1Syad
$BLRX Bullish pattern forming. Chart by https://t.co/1MjnDHV7ua https://t.co/V4DyqEfd1q
January 20th 2022, 6:01pm
winTheWorld2021 @winTheWorld2021
@TOFIQFAZL can $blrx go to moon?
January 20th 2022, 3:01pm
winTheWorld2021 @winTheWorld2021
@TaraBull808 Can $blrx go to moon?
January 20th 2022, 3:01pm
iiiDCP3iii @iiiDCP3iii
Throw $BLRX on that list
January 20th 2022, 3:01pm
MaiteMerenda @MaiteMerenda
$BLRX Awaiting Buy Signal. Chart by https://t.co/t5kOjgsWN3 https://t.co/GrUXtDzfAu
January 20th 2022, 1:01pm
mediasentiment @mediasentiment
$BLRX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 382
January 20th 2022, 12:01pm
mediasentiment @mediasentiment
$BLRX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 381
January 20th 2022, 12:01pm
Tickeron @Tickeron
$BLRX in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on January 18, 2022. View odd… https://t.co/FygoX8B7yA
January 20th 2022, 12:01pm
PennySearch @PennySearch
$BLRX HC Wainwright & Co. gave BLRX a Buy stock rating on 2021-02-23. Find top penny stocks with PennySearch bef… https://t.co/2iYm3bsRKJ
January 20th 2022, 5:01am
coreinv1 @coreinv1
@STL_Biotech what am I missing with regards to $BLRX if you have any critical thoughts?
January 19th 2022, 10:01pm
coreinv1 @coreinv1
$BLRX mcap 92m, cash ~60m, stock 52 low, way below post p3 peak of 4.88. EV 32m? Ridiculous! Runway until 2024 curr… https://t.co/z0pQnfHxzJ
January 19th 2022, 10:01pm
coreinv1 @coreinv1
$BLRX patent protection appears to be good. Until 2029. Weird corp pres does not address this head on. A bit minor… https://t.co/EYvdhQjfpc
January 19th 2022, 10:01pm
coreinv1 @coreinv1
$BLRX this is why approval highly likely imho. Patience is only issue. https://t.co/DGLesdV0tI https://t.co/X6CaUyTReE
January 19th 2022, 9:01pm
TheFortuneTell5 @TheFortuneTell5
Commented on $BLRX - BioLineRx: A Top Candidate For A Takeover Before 2022 Ends. https://t.co/fxWocEXfVl
January 19th 2022, 7:01pm
coreinv1 @coreinv1
$BLRX good pre-NDA meeting, filing this year, stock back to before good trial results in May 2021... doubled at $2.… https://t.co/tZsj0KDj1B
January 19th 2022, 6:01pm
thebiotechbean @thebiotechbean
RT @TheFortuneTell5: Commented on $BLRX - BioLineRx: A Top Candidate For A Takeover Before 2022 Ends. https://t.co/kzR4GV9eSd
January 19th 2022, 5:01pm
TheFortuneTell5 @TheFortuneTell5
Commented on $BLRX - BioLineRx: A Top Candidate For A Takeover Before 2022 Ends. https://t.co/kzR4GV9eSd
January 19th 2022, 5:01pm
alerts_real @alerts_real
RT @Gularfnm: $BLRX BioLineRx Announces Successful Completion of Pre-NDA Meeting with FDA for Motixafortide for Stem Cell Mobilization in M…
January 19th 2022, 5:01pm
alerts_real @alerts_real
RT @TheFortuneTell5: Commented on $BLRX - BioLineRx: A Top Candidate For A Takeover Before 2022 Ends. https://t.co/o5fHabsmUG
January 19th 2022, 5:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.